Home Compliance Novartis Pays Over $642 Million to Settle Allegations of Improper Payments to... ComplianceFCANews Novartis Pays Over $642 Million to Settle Allegations of Improper Payments to Patients and Physicians July 10, 2020 143 Share FacebookLinkedinTwitter Soru Epotok | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Wages War Over: Ohio Court Rules SCA Violations Weren’t FCA Violations Compliance Relator’s Claims Against Federal Grantees Survive Motion to Dismiss Compliance DOJ’s First Intervention in Cybersecurity FCA Qui Tam Case Signals Continued Cyber Enforcement